Nutrition in Oncology: Overcoming Challenges to Optimize the Patient Journey from Prehabilitation to Rehabilitation [0.03%]
肿瘤学营养：克服挑战以优化从术前准备到术后康复的患者旅程
Stanislaw Klek,Alessandro Laviano,Hervé Chrostek et al.
Stanislaw Klek et al.
Patients with cancer are likely to be more malnourished than patients treated in other specialties, with many remaining at high nutritional risk prior to surgery or medical treatment. Malnutrition in patients with cancer can result in subop...
Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations [0.03%]
BELALAMY研究：Belantamab Mafodotin治疗复发难治多发性骨髓瘤患者相关眼部不良事件的临床管理实践指导——拉丁美洲专家共识意见书
Vânia Hungria,Virginia Abello Polo,Ariel Corzo et al.
Vânia Hungria et al.
Multiple myeloma is a significant cause of mortality worldwide, and although changes in the treatment landscape have improved outcomes overall, many patients become refractory to standard therapies. In Latin America, outcomes are especially...
Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours [0.03%]
评估胃肠间质肿瘤患者转换为伊马替尼仿制药的安全性
Joris M van Sabben,Maud B A van der Kleij,Evelyne Roets et al.
Joris M van Sabben et al.
Introduction: Following patent expiration of branded imatinib (Glivec®), all Dutch patients with gastrointestinal stromal tumours (GIST) switched from Glivec to generic forms. Following this switch, many patients reporte...
Advances in the Optimization of CAR-T-Cell-Based Therapeutic Approaches to Enhance Antitumor Efficacy in Glioblastoma Treatment [0.03%]
优化CAR-T细胞治疗胶质母细胞瘤的抗肿瘤疗效的研究进展
Lidia Gatto,Vincenzo Di Nunno,Alicia Tosoni et al.
Lidia Gatto et al.
Chimeric antigen receptor (CAR)-T cell therapy is emerging as a promising immunotherapeutic modality for improving clinical outcomes in high-grade gliomas. Three recent studies have demonstrated the safety and feasibility of intracranial CA...
Drug Utilisation of Radium-223 Under Routine Clinical Practice (DIRECT) in Europe: A Post-Authorisation Safety Study [0.03%]
欧洲药物利用：镭223常规临床实践下的药物应用情况（DIRECT）是一项关于上市后安全性的研究
Rachel Weinrib,Joan Fortuny,David Martinez et al.
Rachel Weinrib et al.
Introduction: Radium-223 is indicated for adults with metastatic castration-resistant prostate cancer (mCRPC) and symptomatic bone metastases, without visceral metastases, who progress after at least (≥) two lines of or ...
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer [0.03%]
帕博利珠单抗联合化疗一线治疗非小细胞肺癌患者中肿瘤应答及应答持续时间对总生存期的影响：KEYNOTE-189研究的事后分析
Marina C Garassino,Ying Cheng,Delvys Rodriguez-Abreu et al.
Marina C Garassino et al.
Introduction: Response Evaluation Criteria in Solid Tumors (RECIST) is the primary tool for assessing tumor response in solid tumors. Immunotherapy elicits unique response patterns, and assessment of their contribution to...
Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence Study [0.03%]
英国真实世界证据研究：免疫检查点抑制剂治疗黑色素瘤和肾细胞癌的免疫相关不良事件的临床管理和结果
Anna Olsson-Brown,Ankit Jain,Ricky Frazer et al.
Anna Olsson-Brown et al.
Introduction: Immune checkpoint inhibitor (ICI) therapy, although effective in treating patients with a variety of advanced malignancies, can result in potentially severe or even fatal immune-related adverse events (irAEs...
Elisa Tiberi,Alessandro Parisi,Mirco Pistelli et al.
Elisa Tiberi et al.
Currently, immunotherapy has led to a paradigmatic shift in the treatment of many cancer types, including triple-negative breast cancer. Immunotherapy increases the efficacy of the immune system in treating cancer, with a durable effect due...
When Neck Dissection is Not Indicated in the Treatment of the Clinically Node-Negative Head and Neck Squamous Cell Carcinoma [0.03%]
当颈部清扫术不用于临床淋巴结阴性的头颈鳞状细胞癌的治疗时
Marc Hamoir,Remco de Bree,Primoz Strojan et al.
Marc Hamoir et al.
Management and Clinical Outcomes of Patients with Advanced Ovarian Cancer in Routine Clinical Practice in Spain: The OVOC Study [0.03%]
西班牙卵巢癌患者常规临床实践的管理及临床转归：卵巢癌研究项目
Maria Quindós-Varela,Diego Soto de Prado-Otero,Alejandro Gallego et al.
Maria Quindós-Varela et al.
Introduction: The OVOC study was carried out to evaluate the management and clinical evolution of patients with advanced ovarian cancer (AOC) in routine clinical practice in Spain. ...